Literature DB >> 23624912

Inhibitor of growth 4 induces NFκB/p65 ubiquitin-dependent degradation.

Y Hou1, Z Zhang1, Q Xu1, H Wang2, Y Xu1, K Chen1.   

Abstract

As a tumor suppressor protein, the inhibitor of growth 4 (ING4) has an important role in many cellular processes including cell cycle progression, proliferation, apoptosis, DNA damage response, tumor angiogenesis and contact inhibition. Here, we report that ING4 functions as an E3 ubiquitin ligase to induce nuclear factor-κB (NFκB)/p65 degradation. The plant homeodomain finger of ING4 interacted with p65 to undergo robust ubiquitination and degradation. ING4 bound to p65 and delivered the Lys-48-linked polyubiquitin to Lys-62 residue of p65, leading to ubiquitination of p65 and degradation. Lys-62 residue of p65 was required for ING4-mediated ubiquitination of p65 and degradation. Further analysis shows that C239 of ING4 was critical for ING4-induced p65 degradation. These findings demonstrate that ING4 acts as an E3 ubiquitin ligase to induce ubiquitination of p65 and degradation, which is critical to terminate NFκB activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624912     DOI: 10.1038/onc.2013.135

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Identifying novel protein phenotype annotations by hybridizing protein-protein interactions and protein sequence similarities.

Authors:  Lei Chen; Yu-Hang Zhang; Tao Huang; Yu-Dong Cai
Journal:  Mol Genet Genomics       Date:  2016-01-04       Impact factor: 3.291

2.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

3.  Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Authors:  Aymen Shatnawi; Sridhar A Malkaram; Tamer Fandy; Efrosini Tsouko
Journal:  Mol Cell Biochem       Date:  2019-11-27       Impact factor: 3.396

Review 4.  Ubiquitin-mediated NFκB degradation pathway.

Authors:  Huimin Xu; Mengli You; Haifeng Shi; Yongzhong Hou
Journal:  Cell Mol Immunol       Date:  2014-10-27       Impact factor: 11.530

5.  Expression of ING4 is negatively correlated with cellular proliferation and microvessel density in human glioma.

Authors:  Bin Shao; Enzhong Liu
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

6.  MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination.

Authors:  Min Cong; Yuan Wang; Yang Yang; Cheng Lian; Xueqian Zhuang; Xiaoxun Li; Peiyuan Zhang; Yingjie Liu; Jun Tang; Qifeng Yang; Xue Zhang; Hua Xiong; Ronggui Hu; Guohong Hu
Journal:  Nat Cancer       Date:  2020-01-20

Review 7.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

Review 8.  Inhibitor of growth-4 is a potential target for cancer therapy.

Authors:  Shuping Yuan; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Tumour Biol       Date:  2016-01-23

9.  Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.

Authors:  H Zhang; X Zhou; C Xu; J Yang; J Xiang; M Tao; Y Xie
Journal:  Cancer Gene Ther       Date:  2015-11-13       Impact factor: 5.987

10.  Friedelin Alleviates the Pathogenesis of Collagenase-Induced Tendinopathy in Mice by Promoting the Selective Autophagic Degradation of p65.

Authors:  Huaji Jiang; Xuemei Lin; Wei Liang; Yiqiang Li; Xiao Yu
Journal:  Nutrients       Date:  2022-04-18       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.